← Eichor
Condition: Thymic Malignancies Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Thymic Malignancies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the L
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05354570CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07429851Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07691619An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT05672251Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06885697Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06301945PT-112 in Subjects With Thymoma and Thymic Carcinoma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05104736First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Art
Phase 2 · 1 location(s) · National Cancer Center, Japan · NCT05832827A Study of KC1036 in Patients with Advanced Thymic Tumors
Phase 2 · 2 location(s) · Beijing Konruns Pharmaceutical Co., Ltd. · NCT05683886Hypofractionated Radiotherapy for Thymic Epithelial Tumors
NA · 1 location(s) · Rongrong Zhou · NCT06692062Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapul
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02146170HEARTS Trial for Thoracic Cancers
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT07132918Molecular Analysis and Treatment Options of Thymic Malignancies
Phase N/A · 1 location(s) · Shanghai Chest Hospital · NCT05667948Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03295227CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07181720Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06941584A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Phase 2 · 4 location(s) · Georgetown University · NCT06248515Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Phase 2 · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT06019468Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · 87 location(s) · SWOG Cancer Research Network · NCT05633615Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06141369Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors
Phase 2 · 1 location(s) · Jian Chen · NCT06186726Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
Phase 2 · 1 location(s) · Jian Chen · NCT06311955Ivonescimab for the Treatment of Thymic Cancer
Phase 2 · 5 location(s) · Jonsson Comprehensive Cancer Center · NCT06980077Establishing Prospective Mediastinal Tumor Database of PUMCH
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06421805Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06838910The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
Phase 2 · 1 location(s) · Jian Chen · NCT06311968Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07598955
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.